Heme Oxygenase Induction Suppresses Hepatic Hepcidin and Rescues Ferroportin and Ferritin Expression in Obese Mice.
Nitin PuriYevgeniy ArefievRobert ChaoDavid SacerdotiHibba ChaudryAlexandra NicholsKrithika SrikanthanAthar NawabDana SharmaVishal Hari LakhaniRebecca KlugKomal SodhiStephen J PetersonPublished in: Journal of nutrition and metabolism (2017)
Hepcidin, a phase II reactant secreted by hepatocytes, regulates cellular iron levels by increasing internalization of ferroportin-a transmembrane protein facilitating egress of cellular iron. Chronic low-grade inflammatory states, such as obesity, have been shown to increase oxidative stress and enhance hepcidin secretion from hepatocytes and macrophages. Heme-heme oxygenase (HO) is a stress response system which reduces oxidative stress. We investigated the effects of HO-1 induction on hepatic hepcidin levels and on iron homeostasis in hepatic tissues from lean and obese mice. Obese mice exhibited hyperglycemia (p < 0.05); increased levels of proinflammatory cytokines (MCP-1, IL-6, p < 0.05); oxidative stress (p < 0.05); and increased hepatic hepcidin levels (p < 0.05). Enhancement of hepcidin was reflected in the reduced expression of ferroportin in obese mice (p < 0.05). However, this effect is accompanied by a significant decline in ferritin expression. Additionally, there are reduced insulin receptor phosphorylation and attenuation of metabolic regulators pAMPK, pAKT, and pLKB1. Cobalt protoporphyrin- (CoPP-) induced HO-1 upregulation in obese mice reversed these alterations (p < 0.05), while attenuating hepatic hepcidin levels. These effects of CoPP were prevented in obese mice concurrently exposed to an inhibitor of HO (SnMP) (p < 0.05). Our results highlight a modulatory effect of HO on iron homeostasis mediated through the suppression of hepatic hepcidin.
Keyphrases
- iron deficiency
- oxidative stress
- poor prognosis
- low grade
- diabetic rats
- type diabetes
- phase ii
- binding protein
- clinical trial
- gene expression
- ischemia reperfusion injury
- dna damage
- randomized controlled trial
- cell proliferation
- transcription factor
- open label
- signaling pathway
- liver injury
- weight loss
- high glucose
- body mass index
- endothelial cells
- protein protein
- amino acid
- mouse model
- mass spectrometry
- postmenopausal women
- bone mineral density